HKU Scholars Hub: Browsing DSpace

Browsing by Author Felip, E

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 2 to 5 of 5 < previous

	Title	Author(s)	Issue Date	Views
	KEYNOTE-495/KeyImPaCT, a randomized, phase 2, biomarker-directed trial of pembrolizumab-based therapy for non–small cell lung cancer (NSCLC) Proceeding/Conference:Annals of Oncology	Gutierrez, M Lam, WS Hellmann, MD Gubens, CA Aggarwal, C Tan, DSW Felip, E Chiu, WYJ Lee, JS Yang, JCH Garon, EB Basso, A Ma, H Fong, L Snyder, A Yuan, J Herbst, RS	2019	77
	KEYNOTE-495/KeyImPaCT: Interim Analysis of a Randomized, Biomarker-Directed, ProgramsPhase 2 Trial of Pembrolizumab-Based Combination Therapy for Non–Small Cell Lung Cancer Proceeding/Conference:The Society for Immunotherapy of Cancer’s (SITC) 36th Annual Meeting & Pre-Conference Programs (SITC 2021)	Gutierrez, M Lam, WS Hellmann, MD Gubens, MA Aggarwal, C Tan, DSW Felip, E Chiu, WYJ Lee, JS Yang, JCH Garon, EB Finocchiaro, G Ahn, MJ Luft, A Landers, GA Basso, A Ma, H Kobie, J Palcza, J Cristescu, R Fong, L Snyder, A Yuan, J Herbst, RS	2021	14
	KEYNOTE-495/KeyImPaCT: Phase II biomarker-directed precision oncology study of pembrolizumab-based combination therapy for non–small cell lung cancer Proceeding/Conference:Cancer Research	Gutierrez, M Hellmann, MD Gubens, MD Aggarwal, CA Tan, DSW Felip, E Chiu, WYJ Lee, JS Yang, JCH Garon, EB Basso, AD Ma, H Fong, L Snyder, A Yuan, J Herbst, RS	2019	44
	Pembrolizumab Plus Pemetrexed and Platinum in Nonsquamous Non-Small-Cell Lung Cancer: 5-Year Outcomes from the Phase 3 KEYNOTE-189 Study Journal:Journal of Clinical Oncology	Garassino, MC Gadgeel, S Speranza, G Felip, E Esteban, E Dómine, M Hochmair, MJ Powell, SF Bischoff, HG Peled, N Grossi, F Jennens, RR Reck, M Hui, R Garon, EB Kurata, T Gray, JE Schwarzenberger, P Jensen, E Pietanza, MC Rodríguez-Abreu, D	10-Apr-2023

Showing results 2 to 5 of 5 < previous